Delirium in Children Undergoing Stem Cell Transplantation

Running, not enrolling

Conditions studied: Stem Cell Transplant Complications, Delirium

In brief

Children undergoing stem cell transplants are at risk for delirium, a temporary change in thinking and behavior. This study will define delirium rates, risk factors, and outcomes. Our eventual goal is to reduce delirium in this population.

Key facts

Study ID

NCT04937400

Run by

Weill Medical College of Cornell University

People needed

1040

Starts

2021-07-12

Expected to finish

2026-07-31

Last updated by the study team

2025-11-14

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 0-21 years old
• Admitted for purpose of stem cell transplant

You may not qualify if…

• Age >21 years old
• Admitted for reason other than stem cell transplant (example: late post-transplant complications).

Where it is running

• University of California San Francisco — San Francisco, California, United States
• Dana Farber Cancer Center — Boston, Massachusetts, United States
• Weill Cornell Medical College — New York, New York, United States
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
• St Jude Children's Research Hospital — Memphis, Tennessee, United States
• Hospital for Sick Children — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.